Lindy Bancke
Impact in
- Gastroenterology top 5%
- Gastrointestinal motility and disorders
- Infectious Diseases top 5%
- Clostridium difficile and Clostridium perfringens research
- Viral gastroenteritis research and epidemiology
Papers in
-
- Clostridium difficile and Clostridium perfringens research 14
- Tuberculosis Research and Epidemiology 1
-
- Microscopic Colitis 2
- Co-authors
- Paul Feuerstadt (12 shared papers)Sahil Khanna (7 shared papers)Thomas Louie (3 shared papers)Christine Lee (2 shared papers)W Knapple (3 shared papers)Julia Garcia‐Diaz (2 shared papers)Gary P. Wang (1 shared paper)Scott Berry (1 shared paper)
- Journals
- Open Forum Infectious Diseases (6 papers)The American Journal of Gastroenterology (2 papers)Neurology (2 papers)Therapeutic Advances in Gastroenterology (2 papers)Epilepsia (1 paper)
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
Lindy Bancke
17 papers receiving 360 citations
Lindy Bancke's Hit Papers
Peers
Comparison fields: 5 of 47
- Gastroenterology 84
- Infectious Diseases 289
- Epidemiology 112
- Critical Care and Intensive Care Medicine 10
- Molecular Biology 117
Countries citing papers authored by Lindy Bancke
This map shows the geographic impact of Lindy Bancke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lindy Bancke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lindy Bancke more than expected).
Fields of papers citing papers by Lindy Bancke
This network shows the impact of papers produced by Lindy Bancke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lindy Bancke. The network helps show where Lindy Bancke may publish in the future.
Co-authors
The 25 scholars most cited alongside Lindy Bancke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection Hit paper breakdown → | 2022 | 189 |
| 2 | 2023 | 54 | |
| 3 | 2015 | 28 | |
| 4 | 2024 | 20 | |
| 5 | 2023 | 17 | |
| 6 | 2023 | 15 | |
| 7 | 2021 | 8 | |
| 8 | 2022 | 8 | |
| 9 | 2024 | 7 | |
| 10 | 2023 | 6 | |
| 11 | 2021 | 5 | |
| 12 | 2022 | 2 | |
| 13 | 2013 | 2 | |
| 14 | 2019 | 2 | |
| 15 | 2013 | 2 | |
| 16 | 2021 | 1 | |
| 17 | 2022 | 1 | |
| 18 | 2025 | 0 |
About Lindy Bancke
Lindy Bancke is a scholar working on Infectious Diseases, Epidemiology, Molecular Biology, Critical Care and Intensive Care Medicine and Neurology, having authored 18 papers that have together received 367 indexed citations. Recurring topics across this work include Clostridium difficile and Clostridium perfringens research (14 papers), Gut microbiota and health (2 papers), Microscopic Colitis (2 papers), Epilepsy research and treatment (2 papers), Neonatal and fetal brain pathology (2 papers), Nosocomial Infections in ICU (2 papers), Botulinum Toxin and Related Neurological Disorders (2 papers) and Tuberculosis Research and Epidemiology (1 paper). The work is most often cited by research in Gastroenterology (84 citations), Infectious Diseases (289 citations), Epidemiology (112 citations), Critical Care and Intensive Care Medicine (10 citations) and Molecular Biology (117 citations). Lindy Bancke has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Paul Feuerstadt, Sahil Khanna, Thomas Louie, Christine Lee, W Knapple, Julia Garcia‐Diaz, Gary P. Wang, Scott Berry, Humberto Aguilar and Xin Su. Their work appears in journals such as Open Forum Infectious Diseases, The American Journal of Gastroenterology, Neurology, Therapeutic Advances in Gastroenterology and Epilepsia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.